Sign In

Memorial Hospital Hosts Clinical Trial for the Treatment of Heart Failure

Last updated 4 years ago

Memorial Hospital today announces its participation as the only local hospital enrolling patients in an important trial that shows promise for the treatment of chronic, advanced heart failure.

The CUPID Trial is a gene therapy study that seeks to find a better, more effective treatment for patients with severe heart failure. In this trial, the gene therapy treatment, MYDICAR®, is given to one group of patients while a placebo is given to another group. Early data showed that patients treated with MYDICAR® became stabilized at 12 months, while the health of those who received the placebo tended to deteriorate as typically occurs in patients with heart failure.

Dr. Michael Koren, the current President of both the Jacksonville Center for Clinical Research and the metro-DC based organization Academy of Physicians in Clinical Research, is the cardiologist who will oversee the trial as Principal Investigator with the participation of other Memorial Hospital based Cardiology Specialists.

Memorial Hospital hosts numerous clinical trials every year, as its doctors look to find treatment for serious diseases and medical conditions.

 

  • Loading comments... Spinner
Do you like Memorial Hospital?
Connect With Us on Facebook!





Links

Disclaimer: The materials provided are intended for informational purposes only. You should contact your doctor for medical advice. Use of and access to this website or other materials do not create a physician-patient relationship. The opinions expressed through this website are the opinions of the individual author and may not reflect the opinions of the hospital, medical staff, or any individual physician or other healthcare professional.
  • Recent Posts
    • Loading posts... Spinner
  • View All
  • Recent Comments
    • Loading comments... Spinner
  • Related Links
  • Popular Tags
    • Loading tags... Spinner